Education
About Us
Working with TipRanks
Follow Us
Sanofi SA (SNY)
:SNY
Rilzabrutinib
Immune Thrombocytopenia
Phase III
Not Yet Recruiting
Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
Oct 09, 2025
―
Dupilumab
Severe Atopic Dermatitis (Ad)
Phase IV
Not Yet Recruiting
Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab
Sep 15, 2025
―
Brivekimig
Hidradenitis Suppurativa
Phase II
Not Yet Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Sep 05, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sanofi SA (SNY) have in its pipeline
SNY is currently developing the following drugs: Rilzabrutinib, Dupilumab, Brivekimig. These drug candidates are in various stages of clinical development as the company works toward FDA approval.